Evidence map›Paper›PMID 26415026›Full record

ArticleFree radical biology & medicine2015

Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.

Hao Wu, Lili Kong, Yanli Cheng, Zhiguo Zhang, Yangwei Wang, Manyu Luo, Yi Tan, Xiangmei Chen, Lining Miao, Lu Cai

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Article
  3. NRF2 Dysregulation and Therapeutic Insights Across Chronic Kidney Diseases.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Nrf2 Activation Attenuates Acrylamide-Induced Neuropathy in Mice.International journal of molecular sciences · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Hao WuDepartment of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin, China, 130041; Kosair Children's Hospital Research Institute at the Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, Louisville, KY, USA, 40202.
Lili KongDepartment of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin, China, 130041; Kosair Children's Hospital Research Institute at the Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, Louisville, KY, USA, 40202.
Yanli ChengKosair Children's Hospital Research Institute at the Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, Louisville, KY, USA, 40202; The First Hospital of Jilin University, Changchun, Jilin, China, 130021.
Zhiguo ZhangKosair Children's Hospital Research Institute at the Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, Louisville, KY, USA, 40202; The First Hospital of Jilin University, Changchun, Jilin, China, 130021.
Yangwei WangDepartment of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin, China, 130041.
Manyu LuoDepartment of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin, China, 130041; Kosair Children's Hospital Research Institute at the Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, Louisville, KY, USA, 40202.
Yi TanKosair Children's Hospital Research Institute at the Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, Louisville, KY, USA, 40202; Chinese-American Research Institute for Diabetic Complications, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China, 325200.
Xiangmei ChenDepartment of Nephrology, Chinese PLA General Hospital, Beijing, China, 100853.
Lining MiaoDepartment of Nephrology, the Second Hospital of Jilin University, Changchun, Jilin, China, 130041. Electronic address: miaolining55@163.com.
Lu CaiKosair Children's Hospital Research Institute at the Department of Pediatrics, Wendy L. Novak Diabetes Care Center, University of Louisville, Louisville, KY, USA, 40202; Chinese-American Research Institute for Diabetic Complications, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China, 325200. Electronic address: l0cai001@louisville.edu.
University of Louisville · USDiabetes Care Center · USSecond Affiliated Hospital of Jilin University · CNChinese PLA General Hospital · CNKosair Children's Hospital · USWenzhou Medical University · CN

Funding

Metabolomics study on the preventive mechanisms for LDR on diabetic nephropathyR01DK091338 · NIDDK · UNIVERSITY OF LOUISVILLE · PI CAI, LU · 2013 to 2014
$900k
NIDDK NIH HHS 1R01DK 091338-01A1NIDDK NIH HHS R01 DK091338
6 · The paper itself

Abstract

Sulforaphane (SFN) prevents diabetic nephropathy (DN) in type 1 diabetes via up-regulation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2). However, it has not been addressed whether SFN also prevents DN from type 2 diabetes or which Nrf2 downstream gene(s) play(s) the key role in SFN renal protection. Here we investigated whether Nrf2 is required for SFN protection against type 2 diabetes-induced DN and whether metallothionein (MT) is an Nrf2 downstream antioxidant using Nrf2 knockout (Nrf2-null) mice. In addition, MT knockout mice were used to further verify if MT is indispensable for SFN protection against DN. Diabetes-increased albuminuria, renal fibrosis, and inflammation were significantly prevented by SFN, and Nrf2 and MT expression was increased. However, SFN renal protection was completely lost in Nrf2-null diabetic mice, confirming the pivotal role of Nrf2 in SFN protection from type 2 diabetes-induced DN. Moreover, SFN failed to up-regulate MT in the absence of Nrf2, suggesting that MT is an Nrf2 downstream antioxidant. MT deletion resulted in a partial, but significant attenuation of SFN renal protection from type 2 diabetes, demonstrating a partial requirement for MT for SFN renal protection. Therefore, the present study demonstrates for the first time that as an Nrf2 downstream antioxidant, MT plays an important, though partial, role in mediating SFN renal protection from type 2 diabetes.

Indexed as

AnimalsAnticarcinogenic AgentsBlotting, WesternDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diabetic NephropathiesImmunoenzyme TechniquesIsothiocyanatesMaleMetallothioneinMiceMice, Inbred C57BLMice, KnockoutNF-E2-Related Factor 2Oxidative StressReal-Time Polymerase Chain ReactionAnticarcinogenic AgentsIsothiocyanatesMetallothioneinNF-E2-Related Factor 2RNA, MessengersulforaphaneSulfoxidesDiabetesFibrosisInflammationKidneyOxidative stress

Identifiers

PMID26415026
PMCPMC4684781
OpenAlexW1789479632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.